PD-068 An exploratory analysis of a phase III study in patients with advanced non-small cell lung cancer (NSCLC): The impact of first-line gemcitabine and platinum therapy on the outcome of second-line therapy with pemetrexed or docetaxel

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Lung Cancer

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0169-5002(05)80401-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?

  2008cites this paper
• Second-line chemotherapy for non-small cell lung cancer

  2006cites this paper
• Second-line therapeutic options in non-small-cell lung cancer.

  2006cites this paper
• An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer

  2005cites this paper